Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Control Groups × 90 days × Clear all

Sponsor

Conditions

Neoplasms 3 Motor Activity 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Vomiting 1 Uterine Cervical Neoplasms 1 Ulcer 1 Stomatitis 1 Sleep Initiation and Maintenance Disorders 1 Polycystic Ovary Syndrome 1 Pediatric Brain Tumor 1 Pathologic Processes 1 Papillomavirus Infections 1 Nausea 1 Lymphatic Metastasis 1 Liver Diseases 1 Liver Cirrhosis 1 Keratosis, Actinic 1 Hematologic Neoplasms 1 Gastrostomy 1 Fatigue 1 Disease 1 Cancer Pain 1 Breast Neoplasms 1

Interventions

pembrolizumab 55 Cisplatin 35 Cetuximab 26 Carboplatin 24 Radiotherapy 18 Radiotherapy, Intensity-Modulated 17 Magnetic Resonance Spectroscopy 16 Specimen Handling 14 Paclitaxel 14 Nivolumab 14 Docetaxel 14 Platinum 8 Fluorouracil 8 1,2-diaminocyclohexaneplatinum II citrate 8 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 6 atezolizumab 5 Radiation 5 Ipilimumab 5 Drug Therapy 5 durvalumab 4 cemiplimab 4 Taxes 4 Standard of Care 4 Radiosurgery 4 Immunoglobulin G 4 Immune Checkpoint Inhibitors 4 Cyclophosphamide 4 Chemoradiotherapy 4 toripalimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡